AMEX: MYO
Myomo, Inc.
Healthcare · Medical - Devices
Market Cap
$49.46M
52w High
$2.68
52w Low
$0.61
P/E
-3.58
Volume
927.45K
Outstanding Shares
38.64M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 52.77% over the last year. Revenue grew 6.68% over the trailing twelve months. Operating margin moved from -15.11% to -34.07%. Free cash flow declined 269.56% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/S, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -34.07%. Free cash flow fell 269.56% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Myomo, Inc. is a medical technology company specializing in wearable robotics.
Valuation
Stock splits
Every 30 shares became 1
Profitability & growth
Analyst consensus
7
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 10, 2026
Q3 FY26 · EPS est -$0.10 · Revenue est $10.35M
View